Skip to the page

Data / Drug companies / Hunan Jiudian Pharmaceutical Co.,Ltd.

Hunan Jiudian Pharmaceutical Co.,Ltd.: 15 products in the FDA NDC directory, labeler code 49574

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Hunan Jiudian Pharmaceutical Co.,Ltd. (labeler code 49574) lists 15 products in the FDA National Drug Code Directory. By type: 15 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on June 5, 2024.

The request: Watch Hunan Jiudian Pharmaceutical Co.,Ltd. (FDA labeler code 49574): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
49574
Products in commercial distribution
15
Packages
18
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
October 1, 2004
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients15100%

Products by type

TypeProductsShare
Bulk ingredients15100%

Dosage forms

Dosage formProductsShare
Powder1386.7%
Liquid213.3%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Dimethyl sulfoxide49574-530LiquidBulk ingredientsJune 5, 2024
Simethicone49574-529LiquidBulk ingredientsMay 4, 2022
Tofacitinib citrate49574-523PowderBulk ingredientsAugust 11, 2021
Levocetirizine dihydrochloride49574-521PowderBulk ingredientsJune 1, 2019
Docusate sodium49574-520PowderBulk ingredientsJune 1, 2019
Docusate sodium49574-519PowderBulk ingredientsJune 1, 2019
Sodium thiosulfate49574-518PowderBulk ingredientsJune 1, 2019
Sumatriptan succinate49574-517PowderBulk ingredientsJune 1, 2019
Secnidazole49574-526PowderBulk ingredientsMay 1, 2019
Moxifloxacin hydrochloride49574-522PowderBulk ingredientsApril 2, 2019
Mannitol49574-527PowderBulk ingredientsApril 1, 2019
Docusate sodium49574-528PowderBulk ingredientsApril 1, 2018
Allantoin49574-516PowderBulk ingredientsMay 1, 2017
Sodium phosphate, monobasic, monohydrate49574-525PowderBulk ingredientsOctober 1, 2004
Sodium phosphate, dibasic, anhydrous49574-524PowderBulk ingredientsOctober 1, 2004

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.